{"id":"W2953738724","doi":"10.1016/j.jval.2019.04.228","title":"PCN104 OBINUTUZUMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: AN IMPORTANT CLINICAL AND COST-EFFECTIVE OPTION FOR HIGH-RISK (INTERMEDIATE/HIGH FLIPI) PATIENTS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Follicular lymphoma; Obinutuzumab; Hazard ratio; Internal medicine; Rituximab; Population; Regimen; Oncology; Confidence interval; Surgery; Progression-free survival; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001957641,0.0001793189,0.0002853095,0.0003768888,0.00100957,0.001304348,0.0005287228,0.0004744127,0.008909523],"category_scores_gemma":[0.0007345789,0.0001140004,0.0002698443,0.0007430193,0.0005232437,0.0003327394,0.000364337,0.0008485495,0.0005486842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01731059,"about_ca_system_score_gemma":0.02853769,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8298068,"about_ca_topic_score_gemma":0.9423425,"domain_scores_codex":[0.9997759,0.00002251752,0.000009229432,0.0000191416,0.00005768923,0.0001155841],"domain_scores_gemma":[0.9994111,0.00003585216,0.00004741973,0.000007081557,0.0001178789,0.0003807818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004857176,0.0008242125,0.1800262,0.0006139167,0.0001638312,0.004402227,0.0003625971,0.002493442,0.00653372,0.004560265,0.09217457,0.7029877],"study_design_scores_gemma":[0.002761776,0.002226359,0.6576447,0.001727432,0.0006899932,0.008192754,0.003640865,0.006684758,0.004363431,0.005380193,0.3065293,0.0001584079],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7337131,0.06611599,0.001149506,0.08390608,0.0007605417,0.000444631,0.003370898,0.0002299426,0.1103093],"genre_scores_gemma":[0.9570594,0.01875297,0.001823351,0.005528332,0.0003194438,0.00004230013,0.001211934,0.0000406571,0.01522161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1701932,"threshold_uncertainty_score":0.342391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01568608151706712,"score_gpt":0.2886828589116048,"score_spread":0.2729967773945377,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}